Themis Medicare Ratios

Themis Medicare Ltd Ratios

The Themis Medicare Ltd Ratios page provides a complete fundamental analysis of Themis Medicare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Themis Medicare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Themis Medicare Ltd (NSE: THEMISMED, BSE: 530199) is currently trading at ₹85.80, with a market capitalization of ₹7.95B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Themis Medicare Ltd remains a key stock for fundamental analysis using Themis Medicare Ltd Ratios.

Themis Medicare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Themis Medicare Ltd P/E ratio currently stands at 45.33, making it one of the most tracked metrics in Themis Medicare Ltd Ratios.

Historically, the Themis Medicare Ltd P/E ratio has shown strong fluctuations:

• 2024: 45.33
• 2023: 46.40
• 2022: 18.90
• 2021: 11.80
• 2020: 7.22

The decline in Themis Medicare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Themis Medicare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.35.

Historical P/B trend:

• 2024: 3.35
• 2023: 5.34
• 2022: 3.16
• 2021: 2.99

Themis Medicare Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Themis Medicare Ltd P/S ratio currently stands at 3.33, an important part of Themis Medicare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 3.33
• 2023: 5.29
• 2022: 3.03
• 2021: 2.18

A stable or declining Themis Medicare Ltd P/S ratio indicates cautious market sentiment.

Themis Medicare Ltd Price to Cash Flow Ratio (P/CF)

The Themis Medicare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 54.82.

Historical Themis Medicare Ltd Price to Cash Flow Ratio:

• 2024: 54.82
• 2023: 101.24
• 2022: 82.88
• 2021: 26.73
• 2020: 4.95

The declining Themis Medicare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Themis Medicare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Themis Medicare Ltd EV currently stands at ₹14.22B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 14.22B
• 2023: 20.96B
• 2022: 11.49B
• 2021: 9.13B

Themis Medicare Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Themis Medicare Ltd EV/EBITDA ratio is currently 28.98, a key metric in Themis Medicare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 28.98
• 2023: 40.69
• 2022: 17.03
• 2021: 9.55

Stable Themis Medicare Ltd EV/EBITDA indicates balanced valuation.

Themis Medicare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Themis Medicare Ltd D/E ratio is currently 0.21, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.21
• 2023: 0.25
• 2022: 0.27
• 2021: 0.28

Themis Medicare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Themis Medicare Ltd ROE currently stands at 7.65%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 7.65
• 2023: 12.14
• 2022: 18.15
• 2021: 28.81

Declining ROE indicates pressure on profitability.

Themis Medicare Ltd Ratios Analysis Summary

The Themis Medicare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Themis Medicare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Themis Medicare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.